Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aura Biosciences (AURA) Tax Provisions (2023 - 2026)

Aura Biosciences filings provide 4 years of Tax Provisions readings, the most recent being $11000.0 for Q1 2026.

  • Quarterly Tax Provisions fell 45.0% to $11000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $93000.0 through Mar 2026, up 6.9% year-over-year, with the annual reading at $108000.0 for FY2025, 3.57% down from the prior year.
  • Tax Provisions hit $11000.0 in Q1 2026 for Aura Biosciences, up from $8000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $137000.0 in Q4 2023 and bottomed at $8000.0 in Q4 2025.
  • Average Tax Provisions over 4 years is $40777.8, with a median of $26000.0 recorded in 2025.
  • The largest annual shift saw Tax Provisions tumbled 82.48% in 2024 before it tumbled 39.53% in 2025.
  • Aura Biosciences' Tax Provisions stood at $137000.0 in 2023, then tumbled by 82.48% to $24000.0 in 2024, then tumbled by 66.67% to $8000.0 in 2025, then surged by 37.5% to $11000.0 in 2026.
  • Per Business Quant, the three most recent readings for AURA's Tax Provisions are $11000.0 (Q1 2026), $8000.0 (Q4 2025), and $26000.0 (Q3 2025).